| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.81B | -0.9% |
| R&D Expense | $200.0M | -12.7% |
| SG&A Expense | $299.0M | +8.3% |
| Pre-tax Income | -$2.03B | -3882.4% |
| Income Tax | $526.0M | +15.6% |
| Net Income | -$2.49B | -481.4% |
| EPS (Basic) | -$2.97 | -450.0% |
| EPS (Diluted) | -$2.97 | -450.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.00B | +4.3% |
| Short-term Investments | $23.0M | -97.4% |
| Accounts Receivable | $734.0M | +100.5% |
| Current Assets | $7.51B | +15.3% |
| Total Assets | $55.51B | +44.2% |
| Current Liabilities | $6.00B | +105.0% |
| Long-term Debt | $8.87B | +59.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.76B | -14.2% |
| Investing Cash Flow | -$1.00B | +66.4% |
| Financing Cash Flow | -$1.60B | +32.0% |
| Total Liabilities |
| $26.30B |
| +38.8% |
| Stockholders' Equity | $29.03B | +50.0% |